<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="Sciences : Microbiology : Medical Microbiology : Microbial Pathogens :" exact="Viral" post="Pathogens : Flaviviruses: Zika Virus : Medicine and Health"/>
 <result pre="Pathology and Laboratory Medicine : Pathogens : Microbial Pathogens :" exact="Viral" post="Pathogens : Flaviviruses: Zika Virus : Biology and Life"/>
 <result pre=": Biology and Life Sciences : Organisms : Viruses :" exact="Viral" post="Pathogens : Flaviviruses: Zika Virus : People and places"/>
 <result pre="and health sciences : Clinical medicine : Clinical immunology :" exact="Autoimmune" post="diseases: Guillain-Barre syndrome : Biology and life sciences :"/>
 <result pre="sciences : Clinical medicine : Clinical immunology : Autoimmune diseases:" exact="Guillain-Barre syndrome" post=": Biology and life sciences : Immunology : Clinical"/>
 <result pre=": Clinical medicine : Clinical immunology : Autoimmune diseases: Guillain-Barre" exact="syndrome" post=": Biology and life sciences : Immunology : Clinical"/>
 <result pre="Biology and life sciences : Immunology : Clinical immunology :" exact="Autoimmune" post="diseases: Guillain-Barre syndrome : Medicine and health sciences :"/>
 <result pre="life sciences : Immunology : Clinical immunology : Autoimmune diseases:" exact="Guillain-Barre syndrome" post=": Medicine and health sciences : Immunology : Clinical"/>
 <result pre="sciences : Immunology : Clinical immunology : Autoimmune diseases: Guillain-Barre" exact="syndrome" post=": Medicine and health sciences : Immunology : Clinical"/>
 <result pre="Medicine and health sciences : Immunology : Clinical immunology :" exact="Autoimmune" post="diseases: Guillain-Barre syndrome : Medicine and Health Sciences :"/>
 <result pre="health sciences : Immunology : Clinical immunology : Autoimmune diseases:" exact="Guillain-Barre syndrome" post=": Medicine and Health Sciences : Congenital Disorders :"/>
 <result pre="sciences : Immunology : Clinical immunology : Autoimmune diseases: Guillain-Barre" exact="syndrome" post=": Medicine and Health Sciences : Congenital Disorders :"/>
 <result pre="Autoimmune diseases: Guillain-Barre syndrome : Medicine and Health Sciences :" exact="Congenital" post="Disorders : Birth Defects: Microcephaly : Biology and Life"/>
 <result pre="diseases: Guillain-Barre syndrome : Medicine and Health Sciences : Congenital" exact="Disorders" post=": Birth Defects: Microcephaly : Biology and Life Sciences"/>
 <result pre="Medicine and Health Sciences : Congenital Disorders : Birth Defects:" exact="Microcephaly" post=": Biology and Life Sciences : Developmental Biology :"/>
 <result pre=": Birth Defects: Microcephaly : Biology and Life Sciences :" exact="Developmental" post="Biology : Morphogenesis : Birth Defects: Microcephaly : Medicine"/>
 <result pre="Life Sciences : Developmental Biology : Morphogenesis : Birth Defects:" exact="Microcephaly" post=": Medicine and Health Sciences : Tropical Diseases :"/>
 <result pre="Birth Defects: Microcephaly : Medicine and Health Sciences : Tropical" exact="Diseases" post=": Neglected Tropical Diseases: Chikungunya Infection : Medicine and"/>
 <result pre="Health Sciences : Tropical Diseases : Neglected Tropical Diseases: Chikungunya" exact="Infection" post=": Medicine and Health Sciences : Infectious Diseases :"/>
 <result pre="Tropical Diseases: Chikungunya Infection : Medicine and Health Sciences :" exact="Infectious" post="Diseases : Viral Diseases: Chikungunya Infection : Medicine and"/>
 <result pre="Diseases: Chikungunya Infection : Medicine and Health Sciences : Infectious" exact="Diseases" post=": Viral Diseases: Chikungunya Infection : Medicine and Health"/>
 <result pre="Infection : Medicine and Health Sciences : Infectious Diseases :" exact="Viral" post="Diseases: Chikungunya Infection : Medicine and Health Sciences: Epidemiology"/>
 <result pre="and Health Sciences : Infectious Diseases : Viral Diseases: Chikungunya" exact="Infection" post=": Medicine and Health Sciences: Epidemiology : Biology and"/>
 <result pre="Sciences : Microbiology : Medical Microbiology : Microbial Pathogens :" exact="Viral" post="Pathogens : Togaviruses : Alphaviruses: Chikungunya Virus : Medicine"/>
 <result pre="Pathology and Laboratory Medicine : Pathogens : Microbial Pathogens :" exact="Viral" post="Pathogens : Togaviruses : Alphaviruses: Chikungunya Virus : Biology"/>
 <result pre=": Biology and Life Sciences : Organisms : Viruses :" exact="Viral" post="Pathogens : Togaviruses : Alphaviruses: Chikungunya Virus : Medicine"/>
 <result pre=": Alphaviruses: Chikungunya Virus : Medicine and Health Sciences :" exact="Infectious" post="Diseases: Vector-Borne Diseases New estimates of the Zika virus"/>
 <result pre="Virus : Medicine and Health Sciences : Infectious Diseases: Vector-Borne" exact="Diseases" post="New estimates of the Zika virus epidemic attack rate"/>
 <result pre="Brazil from 2015 to 2016: A modelling analysis based on" exact="Guillain-Barré" post="Syndrome (GBS) surveillance data Zika versus Guillain-Barré Syndrome http://orcid.org/0000-0003-3253-654XHeDaihaiConceptualizationFormal"/>
 <result pre="from 2015 to 2016: A modelling analysis based on Guillain-Barré" exact="Syndrome" post="(GBS) surveillance data Zika versus Guillain-Barré Syndrome http://orcid.org/0000-0003-3253-654XHeDaihaiConceptualizationFormal analysisMethodologyProject"/>
 <result pre="analysis based on Guillain-Barré Syndrome (GBS) surveillance data Zika versus" exact="Guillain-Barré" post="Syndrome http://orcid.org/0000-0003-3253-654XHeDaihaiConceptualizationFormal analysisMethodologyProject administrationSupervisionWriting – review &amp;amp; editing1*http://orcid.org/0000-0001-8722-6149ZhaoShiData curationFormal"/>
 <result pre="based on Guillain-Barré Syndrome (GBS) surveillance data Zika versus Guillain-Barré" exact="Syndrome" post="http://orcid.org/0000-0003-3253-654XHeDaihaiConceptualizationFormal analysisMethodologyProject administrationSupervisionWriting – review &amp;amp; editing1*http://orcid.org/0000-0001-8722-6149ZhaoShiData curationFormal analysisInvestigationMethodologyWriting"/>
 <result pre="China[2], Division of Biostatistics, JC School of Public Health and" exact="Primary" post="Care, Chinese University of Hong Kong, Hong Kong, China[3],"/>
 <result pre="and August 2016, two epidemic waves of Zika virus (ZIKV)" exact="disease" post="swept the Northeastern (NE) region of Brazil. As a"/>
 <result pre="(NE) region of Brazil. As a result, two waves of" exact="Guillain-Barré" post="Syndrome (GBS) were observed concurrently. The mandatory reporting of"/>
 <result pre="region of Brazil. As a result, two waves of Guillain-Barré" exact="Syndrome" post="(GBS) were observed concurrently. The mandatory reporting of ZIKV"/>
 <result pre="Syndrome (GBS) were observed concurrently. The mandatory reporting of ZIKV" exact="disease" post="began region-wide in February 2016, and it is believed"/>
 <result pre="reporting rate has made it difficult to estimate the ZIKV" exact="infection" post="attack rate, and studies in the literature vary widely"/>
 <result pre="reasonably reliable given the severity and easy recognition of the" exact="disease" post="symptoms. In this paper, we aim to estimate the"/>
 <result pre="to estimate the real number of ZIKV cases (i.e., the" exact="infection" post="attack rate) and their dynamics in time, by scaling"/>
 <result pre="when ZIKV reporting rates are not well understood. The overall" exact="infection" post="attack rate (IAR) of ZIKV is estimated to be"/>
 <result pre="examining various asymptomatic scenarios, the IAR is likely to be" exact="lower" post="than 33% over the two ZIKV waves. The risk"/>
 <result pre="33% over the two ZIKV waves. The risk rate from" exact="symptomatic" post="ZIKV infection to develop GBS was estimated as �?"/>
 <result pre="the two ZIKV waves. The risk rate from symptomatic ZIKV" exact="infection" post="to develop GBS was estimated as �? = 0.0061%"/>
 <result pre="reproduction number, R 0 . Our analysis revealed that asymptomatic" exact="infections" post="affect the estimation of ZIKV epidemics and need to"/>
 <result pre="Author summary The mandatory reporting of the Zika virus (ZIKV)" exact="disease" post="began region-wide in February 2016, and it is believed"/>
 <result pre="cases could have been highly under-reported before that. Given the" exact="Guillain-Barré syndrome" post="(GBS) is relatively well reported, the GBS surveillance data"/>
 <result pre="could have been highly under-reported before that. Given the Guillain-Barré" exact="syndrome" post="(GBS) is relatively well reported, the GBS surveillance data"/>
 <result pre="that the attack rate of ZIKV was likely to be" exact="lower" post="than 33% over the two epidemic waves. The risk"/>
 <result pre="33% over the two epidemic waves. The risk rate from" exact="symptomatic" post="ZIKV case to develop GBS was estimated to be"/>
 <result pre="from ARC Discovery Grant DP150102472. DH received support from RGC" exact="General" post="Research Fund 15205119. The funders had no role in"/>
 <result pre="West Africa, although it was considered a relatively mild human" exact="infection" post="that generally results in only fever, rash and possibly"/>
 <result pre="infection that generally results in only fever, rash and possibly" exact="conjunctivitis" post="[3, 10]. By 2007, the virus had escaped Africa"/>
 <result pre="associated with severe neurological disorders linked to birth defects. ZIKV" exact="infection" post="was found to pass from mother to fetus during"/>
 <result pre="to fetus during pregnancy with the potential to result in" exact="microcephaly" post="which causes fetal abnormalities including possible skull collapse [5]."/>
 <result pre="result in microcephaly which causes fetal abnormalities including possible skull" exact="collapse" post="[5]. In addition, since 2014 ZIKV was found to"/>
 <result pre="2014 ZIKV was found to be strongly associated with the" exact="Guillain-Barré syndrome" post="(GBS) amongst a small proportion of those infected [14,"/>
 <result pre="ZIKV was found to be strongly associated with the Guillain-Barré" exact="syndrome" post="(GBS) amongst a small proportion of those infected [14,"/>
 <result pre="of those infected [14, 15]. GBS can result in long-term" exact="muscle" post="weakness, pain, and in some circumstances death [16]. Many"/>
 <result pre="Many studies found a causal link between GBS and ZIKV" exact="disease" post="[17, 18, 19]. In summary, GBS has many times"/>
 <result pre="[15], making the empirical association unusually strong. While considered relatively" exact="benign" post="for decades since 1947, ZIKV disease suddenly became a"/>
 <result pre="strong. While considered relatively benign for decades since 1947, ZIKV" exact="disease" post="suddenly became a major global disease threat. A Public"/>
 <result pre="decades since 1947, ZIKV disease suddenly became a major global" exact="disease" post="threat. A Public Health Emergency of International Concern (PHEIC)"/>
 <result pre="numbers, and dynamics in time, of ZIKV cases. Fig 1" exact="Total" post="ZIKV (top) and GBS (bottom) cases as time series"/>
 <result pre="et al. also found that, the ratio of asymptomatic to" exact="symptomatic" post="infections (asymptomatic ratio) was about 1:1 in the general"/>
 <result pre="al. also found that, the ratio of asymptomatic to symptomatic" exact="infections" post="(asymptomatic ratio) was about 1:1 in the general population"/>
 <result pre="in French Polynesia, the region experienced a Chikungunya virus (CHIKV)" exact="disease" post="outbreak with an estimated 66,000 cases from October 2014"/>
 <result pre="infections. Thus, based on these studies [23, 24], a ZIKV" exact="infection" post="is of (0.32 ÷ 0.136 =) 2.35-fold more likely"/>
 <result pre="2.35-fold more likely to induce GBS when compared to a" exact="CHIKV infection." post="Cauchemez et al. (2016) [21] also found that the"/>
 <result pre="(2016) [21] also found that the risk of ZIKV induced" exact="microcephaly" post="was 95 cases (34-191) per 10,000 women infected in"/>
 <result pre="weekly cases were documented [26]. In addition, local GBS and" exact="microcephaly" post="cases were also recorded. Over the two years, two"/>
 <result pre="also recorded. Over the two years, two waves of ZIKV" exact="disease" post="were accompanied by two waves of reported GBS cases,"/>
 <result pre="which indicated a possible epidemiological association. A striking wave of" exact="microcephaly" post="cases with a 23-week delay to the first ZIKV"/>
 <result pre="identified and discussed in [26]. The delay arises because ZIKV" exact="infections" post="in the first trimester of pregnancy are most likely"/>
 <result pre="the first trimester of pregnancy are most likely to induce" exact="microcephaly" post="[21, 27, 28, 29]). Fig 2 The reported ZIKV"/>
 <result pre="to November 2016. The red dotted line represents weekly ZIKV" exact="disease" post="cases, the dark blue dotted line represents weekly surplus"/>
 <result pre="GBS cases in NE Brazil were largely due to ZIKV" exact="disease" post="rather than CHIKV, for two reasons: (i) ZIKV is"/>
 <result pre="on the fact that it is difficult to estimate the" exact="infection" post="attack rate (IAR) of ZIKV directly from the reported"/>
 <result pre="in what was felt to be a high number of" exact="microcephaly" post="cases (after a 26-week delay [26]). This is because"/>
 <result pre="microcephaly cases (after a 26-week delay [26]). This is because" exact="microcephaly" post="cases are easier to identify and are thus better"/>
 <result pre="are thus better reported [20]. Nevertheless, the reporting criteria of" exact="microcephaly" post="cases also changed significantly over the two years [34]"/>
 <result pre="IAR of ZIKV directly based on the reported number of" exact="microcephaly" post="cases. Also, we would need to consider the effect"/>
 <result pre="to consider the effect of time-varying birth rates if using" exact="microcephaly" post="cases to infer ZIKV cases. However, it seems a"/>
 <result pre="The reporting criteria of GBS should be relatively accurate and" exact="stable" post="owing to the distinct identifiable and severe clinical features"/>
 <result pre="GBS cases time series. Because of the co-circulation of both" exact="dengue fever" post="and ZIKV during the two waves, misdiagnoses of ZIKV"/>
 <result pre="of CHIKV). First, we assume a constant risk ratio between" exact="symptomatic" post="ZIKV cases and reported GBS cases (ZIKV-GBS ratio), denoted"/>
 <result pre="we observe that the GBS-to-ZIKV ratio of 2016 was significantly" exact="lower" post="than in 2015, which was likely due to the"/>
 <result pre="of ZIKV epidemic before 2016 [20]. Daily mean temperature and" exact="total" post="rainfall (beginning from December 1, 2014) data were obtained"/>
 <result pre="S1 Text. We calculated the daily average temperature and the" exact="total" post="rainfall across the six cities and smoothed them with"/>
 <result pre="�? which is the ratio of reported GBS cases to" exact="symptomatic" post="ZIKV cases. In our earlier work, asymptomatic ZIKV cases"/>
 <result pre="model Fig 3 shows the model diagram of the ZIKV" exact="disease" post="transmission pathways of both humans and the mosquito vector."/>
 <result pre="we continue to assume that hosts infected with ZIKV are" exact="infectious" post="during the convalescent stage and can infect other susceptible"/>
 <result pre="of the ZIKV-GBS epidemic model. The black arrows represent the" exact="infection" post="status transition paths. Red dashed arrows represent transmission paths,"/>
 <result pre="and circular compartments represent the vector classes. Red compartments represent" exact="infectious" post="classes, and the grey compartment is the (weekly) excess"/>
 <result pre="to ZIKV, respectively. Please see text below Eq (1) for" exact="complete" post="listing of all compartment codes. It is supposed that"/>
 <result pre="compartment codes. It is supposed that the asymptomatic cases are" exact="infectious" post="at a weaker level than symptomatic cases and do"/>
 <result pre="the asymptomatic cases are infectious at a weaker level than" exact="symptomatic" post="cases and do not develop to the convalescent stage,"/>
 <result pre="class, Eh is the exposed host class (i.e., within ZIKV" exact="infection" post="latent period), Ah denotes the asymptomatic host class, Ih1"/>
 <result pre="vector class, Ev is the exposed vector (i.e., within ZIKV" exact="infection" post="latent period) and Iv denotes the infectious vector class."/>
 <result pre="(i.e., within ZIKV infection latent period) and Iv denotes the" exact="infectious" post="vector class. The parameter �? denotes the ratio of"/>
 <result pre="�? denotes the ratio of reported (excess) GBS cases per" exact="symptomatic" post="case of ZIKV. The model (1) parameters are summarised"/>
 <result pre="v - 1 (10) 8—12 days fixed [45, 48] Asymptomatic" exact="infectious" post="period γ h - 1 (7) 5—10 days assumed"/>
 <result pre="period γ h - 1 (7) 5—10 days assumed Nil" exact="Infectious" post="period γ h 1 - 1 (5) 3—7 days"/>
 <result pre="1 - 1 (5) 3—7 days fixed [6, 47] Convalescent" exact="infectious" post="period γ h 2 - 1 (25) 14—30 days"/>
 <result pre="- 1 (25) 14—30 days fixed [42, 43] Proportion of" exact="symptomatic" post="θ (50%) 20%—80% Nil to be estimated [22] Infectivity"/>
 <result pre="Infectivity scale of convalescent τ (0.3) 0.01—0.99 H→H fixed [6]" exact="Female" post="vector lifespan μ v - 1 (14) 4—35 days"/>
 <result pre="(14) 4—35 days fixed [49, 50, 51] Ratio: reported GBS" exact="symptomatic" post="ZIKV �? 0.001%—0.1% Nil to be estimated [15, 22,"/>
 <result pre="+ I v , where Nh and Nv represent the" exact="total" post="number of hosts and vectors respectively, of which Nv"/>
 <result pre="As in our previous work, it is assumed that the" exact="total" post="mosquito population is given by: N v ( t"/>
 <result pre="mosquitoes appropriately when m(t) increases, and remove the susceptible and" exact="infectious" post="mosquitoes when m(t) decreases to compensate. In other words,"/>
 <result pre="which provides the basic reproduction number of the classical Ross-Macdonald" exact="malaria" post="model [6, 56, 57]. Model fitting and parameter estimation"/>
 <result pre="hidden Markov model) with a &quot;spillover�? rate (�?) from local" exact="symptomatic" post="ZIKV cases. Here �? is the combined effect of"/>
 <result pre="of the GBS reporting ratio and the risk rate of" exact="symptomatic" post="ZIKV inducing GBS i.e., the ratio �? = reported"/>
 <result pre="ZIKV inducing GBS i.e., the ratio �? = reported GBS" exact="symptomatic" post="ZIKV (see Table 1). The simulated (weekly) number of"/>
 <result pre="prior defined in Eq (4). The term T denotes the" exact="total" post="number of weeks during the study period. Our methodology"/>
 <result pre="the weather factors are taken to be one month in" exact="total" post="i.e., τ0 = 3 × 7 + (8 +"/>
 <result pre="time series demonstrate the tight connection between the reported ZIKV" exact="disease" post="and GBS, whose case numbers closely mimic one another"/>
 <result pre="rate of 0.032% i.e., 0.32 GBS cases per 1,000 ZIKV" exact="infections" post="(asymptomatic and symptomatic) calculated in [23], the total cases"/>
 <result pre="1,000 ZIKV infections (asymptomatic and symptomatic) calculated in [23], the" exact="total" post="cases of ZIKV can be approximated according to the"/>
 <result pre="of η (asymptomatic ZIKV relative infectivity) and θ (proportion of" exact="symptomatic" post="ZIKV infections) considered. The θ = 0.5 simulations correspond"/>
 <result pre="= 0.5 simulations correspond to a 1:1 ratio of the" exact="symptomatic" post="to asymptomatic ZIKV infection of [22]. Simulations with θ"/>
 <result pre="to a 1:1 ratio of the symptomatic to asymptomatic ZIKV" exact="infection" post="of [22]. Simulations with θ = 0.2 correspond to"/>
 <result pre="θ = 0.2 correspond to the 4:1 ratio of the" exact="symptomatic" post="to asymptomatic ZIKV infection of [11]. Fig 4 The"/>
 <result pre="to the 4:1 ratio of the symptomatic to asymptomatic ZIKV" exact="infection" post="of [11]. Fig 4 The fitting results for θ"/>
 <result pre="0 ( t ) . The model also fits the" exact="disease" post="surveillance data well. The BIC of the non-mechanistic model"/>
 <result pre="results here is neither coincidental nor artificial. Estimation of the" exact="infection" post="attack rate (IAR) and model parameters The estimates of"/>
 <result pre="the IAR are summarised in Table 2. For the ZIKV" exact="symptomatic" post="ratio parameter, θ, we follow the previous serological study"/>
 <result pre="serological study conducted in French Polynesia that found the asymptomatic:" exact="symptomatic" post="case ratio as 1: 1 in the general population"/>
 <result pre="(η). However, �? is sensitive to the change of the" exact="symptomatic" post="proportion of ZIKV infections (θ). Setting θ = 0.2"/>
 <result pre="sensitive to the change of the symptomatic proportion of ZIKV" exact="infections" post="(θ). Setting θ = 0.2 gives �? = 0.00013,"/>
 <result pre="obtained for �? (�? = 0.00061—ratio of reported GBS to" exact="symptomatic" post="ZIKV), and denote the ZIKV symptomatic ratio as θ,"/>
 <result pre="of reported GBS to symptomatic ZIKV), and denote the ZIKV" exact="symptomatic" post="ratio as θ, as before. �? can be estimated"/>
 <result pre="number of reported GBS) ÷ [reported GBS/symptomatic ZIKV] ÷ (ZIKV" exact="symptomatic" post="ratio), which is the number of the reported GBS/�?/θ."/>
 <result pre="GBS/�?/θ. The IAR equals the number ZIKV cases ÷ the" exact="total" post="population in the NE Brazil. For all pairs of"/>
 <result pre="transmissibility. Results of the sensitivity analysis As is conventional, the" exact="Partial" post="Rank Correlation Coefficients (PRCC) are adopted to perform a"/>
 <result pre="to obtain the target biological quantities (e.g., R 0 and" exact="total" post="number of GBS cases in this study). Finally, PRCCs"/>
 <result pre="the basic reproduction number ( R 0 ) and the" exact="total" post="reported GBS cases. R 0 is most sensitive to"/>
 <result pre="rate, μv), indicating the importance of the mosquitoes role in" exact="disease" post="transmission. The total reported GBS cases are considerably sensitive"/>
 <result pre="the importance of the mosquitoes role in disease transmission. The" exact="total" post="reported GBS cases are considerably sensitive to the proportion"/>
 <result pre="reported GBS cases are considerably sensitive to the proportion of" exact="symptomatic" post="cases (θ), and the ratio (or risk) of excess"/>
 <result pre="and the ratio (or risk) of excess GBS cases to" exact="symptomatic" post="ZIKV infections (�?). Fig 5 The Partial Rank Correlation"/>
 <result pre="ratio (or risk) of excess GBS cases to symptomatic ZIKV" exact="infections" post="(�?). Fig 5 The Partial Rank Correlation Coefficients (PRCC)"/>
 <result pre="GBS cases to symptomatic ZIKV infections (�?). Fig 5 The" exact="Partial" post="Rank Correlation Coefficients (PRCC) of the basic reproduction number,"/>
 <result pre="the basic reproduction number, R 0 , (panel (a)) and" exact="total" post="GBS cases (panel (b)) with respect to model parameters."/>
 <result pre="the SIR modelling approach, and given the ability of an" exact="infection" post="to rapidly spread through a large set of cities"/>
 <result pre="used with care. Previous studies in large populations, such as" exact="measles" post="in England and Wales (population size 50 million [72,"/>
 <result pre="in England and Wales (population size 50 million [72, 73])" exact="cholera" post="in Yemen (population size 27 million [74]), have yielded"/>
 <result pre="studying Zika virus and its impact on human populations including" exact="microcephaly" post="numbers and its relation to GBS. Their analysis heavily"/>
 <result pre="that there is coherence in the dynamics of infectives and" exact="microcephaly" post="populations when aggregated over all NE Brazil. That is"/>
 <result pre="([12, 26]. Based on the parallel between cases of ZIKV" exact="disease" post="and cases of GBS (eg., as seen in Fig"/>
 <result pre="errors in the reporting rate. Our model considers heterogeneity in" exact="symptomatic" post="and asymptomatic ZIKV infections (i.e., θ and η) as"/>
 <result pre="rate. Our model considers heterogeneity in symptomatic and asymptomatic ZIKV" exact="infections" post="(i.e., θ and η) as well as the local"/>
 <result pre="GBS cases time series with different sets of parameters for" exact="symptomatic" post="proportion (θ) and asymptomatic infectivity (η). From a recent"/>
 <result pre="a serological study [22], the ratio �? of GBS to" exact="symptomatic" post="ZIKV cases was found to be 0.00024 and 0.00032"/>
 <result pre="estimate of 2.4 GBS cases per 10,000 ZIKV, i.e., 0.024%," exact="infections" post="estimated using only data from French Polynesia.�? In this"/>
 <result pre="study, the model estimation finds a ratio between GBS and" exact="symptomatic" post="ZIKV cases as �? = 0.000061 or equivalently �?"/>
 <result pre="CI 0.0050%-0.0086%. That is, 1 GBS case per 16,400 ZIKV" exact="symptomatic" post="cases which is approximately one quarter or 25% the"/>
 <result pre="GBS data. We considered different values of θ (proportion of" exact="symptomatic" post="cases) and η (infectivity scale of asymptomatic) in this"/>
 <result pre="the key literature they refer to, &quot;the proportion of asymptomatic" exact="infections" post="(40% with 95%CI of 23-56%) was low compared with"/>
 <result pre="need to be treated with caution. Due to poor surveillance," exact="limited" post="knowledge about the ZIKV reporting ratio and population seropositivity,"/>
 <result pre="Previous estimates of IAR relied on poor ZIKV data in" exact="Brazilian" post="regions: some estimates appear to be less than 20%,"/>
 <result pre="two diseases, the ratio between them is 6.1 (maximum of" exact="microcephaly" post="divided by maximum of GBS wave), which corresponds to"/>
 <result pre="wave), which corresponds to 1 GBS case for every 6.1" exact="microcephaly" post="cases. If we make the reasonable assumption that the"/>
 <result pre="similar, it is clear that GBS is a much rarer" exact="disease" post="than microcephaly. Nevertheless, we still chose to predict ZIKV"/>
 <result pre="chose to predict ZIKV cases based on GBS rather than" exact="microcephaly" post="cases, because of problems in the correct reporting of"/>
 <result pre="microcephaly cases, because of problems in the correct reporting of" exact="microcephaly" post="over the study period. For example, the criteria for"/>
 <result pre="over the study period. For example, the criteria for identifying" exact="microcephaly" post="changed dramatically at different times over the two year"/>
 <result pre="awareness of ZIKV risk, and thus reduced the spread of" exact="infection" post="[70, 78, 79, 80, 81]. Disease control measures were"/>
 <result pre="reduced the spread of infection [70, 78, 79, 80, 81]." exact="Disease" post="control measures were also introduced by some local authorities"/>
 <result pre="of ZIKV. We argue that the reporting rate of ZIKV" exact="disease" post="increased dramatically around February and March of 2016, as"/>
 <result pre="However, our model fitting finds a ratio between GBS and" exact="symptomatic" post="ZIKV cases as �? = 0.000061, or 1 GBS"/>
 <result pre="�? = 0.000061, or 1 GBS case per 16,400 ZIKV" exact="symptomatic" post="cases. Thus, we can conclude that the reporting ratio"/>
 <result pre="cases. Thus, we can conclude that the reporting ratio of" exact="symptomatic" post="ZIKV cases is roughly 16, 400/436 ≈ 38. Namely,"/>
 <result pre="is roughly 16, 400/436 ≈ 38. Namely, for every 38" exact="symptomatic" post="ZIKV cases, there was 1 case reported, over the"/>
 <result pre="to dengue virus were associated with reduced risk of ZIKV" exact="infection" post="and symptoms.�? A similar outcome was noted in Gordon"/>
 <result pre="population immunity. Third, there exists significant spatial heterogeneity in the" exact="Brazilian" post="population distribution [35]. Messina et al. [85] reported that"/>
 <result pre="1952;46(5):509–20. 10.1016/0035-9203(52)90042-412995440 2DáM, CauseyOR, CareyDE, ReddyS, CookeAR, AkinkugbeFM, et al.Arthropod-borne" exact="viral" post="infections of man in Nigeria, 1964–1970. Annals of Tropical"/>
 <result pre="10.1016/0035-9203(52)90042-412995440 2DáM, CauseyOR, CareyDE, ReddyS, CookeAR, AkinkugbeFM, et al.Arthropod-borne viral" exact="infections" post="of man in Nigeria, 1964–1970. Annals of Tropical Medicine"/>
 <result pre="Zika virus: history of a newly emerging arbovirus. The Lancet" exact="Infectious" post="diseases. 2016;16(7):e119–26. 10.1016/S1473-3099(16)30010-X27282424 4PetersenLR, JamiesonDJ, PowersAM, HoneinM. Zika virus."/>
 <result pre="CarterD, AaronsEJ, et al.Detection of Zika virus in semen. Emerging" exact="infectious diseases." post="2016;22(5):94010.3201/eid2205.16010727088817 9MussoD, RocheC, RobinE, NhanT, TeissierA, Cao-LormeauV. Potential sexual"/>
 <result pre="NhanT, TeissierA, Cao-LormeauV. Potential sexual transmission of Zika virus. Emerging" exact="infectious diseases." post="2015;21(2):35910.3201/eid2102.14136325625872 10World Health Organization official website. Zika virus fact"/>
 <result pre="201620161. 13CamposGS, BandeiraAC, SardiS. Zika virus outbreak, Bahia, Brazil. Emerging" exact="infectious diseases." post="2015;21(10):188510.3201/eid2110.15084726401719 14OehlerE, WatrinL, LarreP, Leparc-GoffartI, LastereS, ValourF, et al.Zika"/>
 <result pre="diseases. 2015;21(10):188510.3201/eid2110.15084726401719 14OehlerE, WatrinL, LarreP, Leparc-GoffartI, LastereS, ValourF, et al.Zika" exact="virus infection" post="complicated by Guillain-Barré syndrome–case report, French Polynesia, December 2013."/>
 <result pre="2015;21(10):188510.3201/eid2110.15084726401719 14OehlerE, WatrinL, LarreP, Leparc-GoffartI, LastereS, ValourF, et al.Zika virus" exact="infection" post="complicated by Guillain-Barré syndrome–case report, French Polynesia, December 2013."/>
 <result pre="LarreP, Leparc-GoffartI, LastereS, ValourF, et al.Zika virus infection complicated by" exact="Guillain-Barré" post="syndrome–case report, French Polynesia, December 2013. Eurosurveillance. 2014;19(9):2072010.2807/1560-7917.ES2014.19.9.2072024626205 15Mier-y"/>
 <result pre="December 2013. Eurosurveillance. 2014;19(9):2072010.2807/1560-7917.ES2014.19.9.2072024626205 15Mier-y Teran-RomeroL, DeloreyMJ, SejvarJJ, JohanssonM. Guillain–Barré" exact="syndrome" post="risk among individuals infected with Zika virus: a multi-country"/>
 <result pre="assessment. BMC medicine. 2018;16(1):6710.1186/s12916-018-1052-429759069 16The World Health Organization official website." exact="Guillain-Barré" post="Syndrome Factsheets;. Available from: http://www.who.int/mediacentre/factsheets/guillain-barre-syndrome/en/. 17XuM, LeeEM, WenZ, ChengY,"/>
 <result pre="BMC medicine. 2018;16(1):6710.1186/s12916-018-1052-429759069 16The World Health Organization official website. Guillain-Barré" exact="Syndrome" post="Factsheets;. Available from: http://www.who.int/mediacentre/factsheets/guillain-barre-syndrome/en/. 17XuM, LeeEM, WenZ, ChengY, HuangWK,"/>
 <result pre="ChengY, HuangWK, QianX, et al.Identification of small-molecule inhibitors of Zika" exact="virus infection" post="and induced neural cell death via a drug repurposing"/>
 <result pre="HuangWK, QianX, et al.Identification of small-molecule inhibitors of Zika virus" exact="infection" post="and induced neural cell death via a drug repurposing"/>
 <result pre="medicine. 2016;22(10):110110.1038/nm.418427571349 18KrauerF, RiesenM, ReveizL, OladapoOT, Martinez-VegaR, PorgoTV, et al.Zika" exact="virus infection" post="as a cause of congenital brain abnormalities and Guillain–Barre"/>
 <result pre="2016;22(10):110110.1038/nm.418427571349 18KrauerF, RiesenM, ReveizL, OladapoOT, Martinez-VegaR, PorgoTV, et al.Zika virus" exact="infection" post="as a cause of congenital brain abnormalities and Guillain–Barre"/>
 <result pre="Martinez-VegaR, PorgoTV, et al.Zika virus infection as a cause of" exact="congenital" post="brain abnormalities and Guillain–Barre syndrome: systematic review. PLoS medicine."/>
 <result pre="2017;14(1):e100220310.1371/journal.pmed.100220328045901 19FontesCA. dos SantosAA, MarchioriE. &quot;Magnetic resonance imaging findings in" exact="Guillain-Barré syndrome" post="caused by Zika virus infection�?. Neuroradiology. 2016;58(8):837–8. 10.1007/s00234-016-1687-927067205 20The"/>
 <result pre="19FontesCA. dos SantosAA, MarchioriE. &quot;Magnetic resonance imaging findings in Guillain-Barré" exact="syndrome" post="caused by Zika virus infection�?. Neuroradiology. 2016;58(8):837–8. 10.1007/s00234-016-1687-927067205 20The"/>
 <result pre="Eyrolle-GuignotD, et al. and others. &quot;Association between Zika virus and" exact="microcephaly" post="in French Polynesia, 2013–15: a retrospective study�?. The Lancet."/>
 <result pre="2017;23(4):669–672. 10.3201/eid2304.16154928084987 23Cao-LormeauVM, BlakeA, MonsS, LastereS, RocheC, VanhomwegenJ, et al.Guillain-Barre" exact="Syndrome" post="outbreak associated with Zika virus infection in French Polynesia:"/>
 <result pre="LastereS, RocheC, VanhomwegenJ, et al.Guillain-Barre Syndrome outbreak associated with Zika" exact="virus infection" post="in French Polynesia: a case-control study. The Lancet. 2016;387(10027):1531–9."/>
 <result pre="RocheC, VanhomwegenJ, et al.Guillain-Barre Syndrome outbreak associated with Zika virus" exact="infection" post="in French Polynesia: a case-control study. The Lancet. 2016;387(10027):1531–9."/>
 <result pre="FournierE, Leparc-GoffartI, LarreP, CubizolleS, SookhareeaC, et al.Increase in cases of" exact="Guillain-Barre syndrome" post="during a Chikungunya outbreak, French Polynesia, 2014 to 2015."/>
 <result pre="Leparc-GoffartI, LarreP, CubizolleS, SookhareeaC, et al.Increase in cases of Guillain-Barre" exact="syndrome" post="during a Chikungunya outbreak, French Polynesia, 2014 to 2015."/>
 <result pre="26de OliveiraWK, CarmoEH, HenriquesCM, CoelhoG, VazquezE, Cortez-EscalanteJ, et al.Zika Virus" exact="Infection" post="and Associated Neurologic Disorders in Brazil. New England Journal"/>
 <result pre="HenriquesCM, CoelhoG, VazquezE, Cortez-EscalanteJ, et al.Zika Virus Infection and Associated" exact="Neurologic" post="Disorders in Brazil. New England Journal of Medicine. 2017;376(16):1591–3."/>
 <result pre="CoelhoG, VazquezE, Cortez-EscalanteJ, et al.Zika Virus Infection and Associated Neurologic" exact="Disorders" post="in Brazil. New England Journal of Medicine. 2017;376(16):1591–3. 10.1056/NEJMc160861228402236"/>
 <result pre="RockKS, YasudaY, KinoshitaR, MiyamatsuYA. theoretical estimate of the risk of" exact="microcephaly" post="during pregnancy with Zika virus infection. Epidemics. 2016;15:66–70. 10.1016/j.epidem.2016.03.00127288540"/>
 <result pre="estimate of the risk of microcephaly during pregnancy with Zika" exact="virus infection." post="Epidemics. 2016;15:66–70. 10.1016/j.epidem.2016.03.00127288540 28EllingtonSR, DevineO, BertolliJ, QuiñonesAM, Shapiro-MendozaCK, Perez-PadillaJ,"/>
 <result pre="pregnant women infected with Zika virus and expected infants with" exact="microcephaly" post="following the Zika virus outbreak in Puerto Rico, 2016."/>
 <result pre="10.1001/jamapediatrics.2016.297427544075 29BrasilP, PereiraJPJr, MoreiraME, Ribeiro NogueiraRM, DamascenoL, WakimotoM, et al.Zika" exact="virus infection" post="in pregnant women in Rio de Janeiro. New England"/>
 <result pre="29BrasilP, PereiraJPJr, MoreiraME, Ribeiro NogueiraRM, DamascenoL, WakimotoM, et al.Zika virus" exact="infection" post="in pregnant women in Rio de Janeiro. New England"/>
 <result pre="Journal of Medicine. 2016;375(24):2321–34. 10.1056/NEJMoa160241226943629 30LebrunG, ChaddaK, RebouxAH, MartinetO, GauzereB." exact="Guillain-Barre syndrome" post="after chikungunya infection. Emerging infectious diseases. 2009;15:310.3201/eid1503.071482 31WielanekAC, De"/>
 <result pre="of Medicine. 2016;375(24):2321–34. 10.1056/NEJMoa160241226943629 30LebrunG, ChaddaK, RebouxAH, MartinetO, GauzereB. Guillain-Barre" exact="syndrome" post="after chikungunya infection. Emerging infectious diseases. 2009;15:310.3201/eid1503.071482 31WielanekAC, De"/>
 <result pre="2016;375(24):2321–34. 10.1056/NEJMoa160241226943629 30LebrunG, ChaddaK, RebouxAH, MartinetO, GauzereB. Guillain-Barre syndrome after" exact="chikungunya" post="infection. Emerging infectious diseases. 2009;15:310.3201/eid1503.071482 31WielanekAC, De MonredonJ, El"/>
 <result pre="ChaddaK, RebouxAH, MartinetO, GauzereB. Guillain-Barre syndrome after chikungunya infection. Emerging" exact="infectious diseases." post="2009;15:310.3201/eid1503.071482 31WielanekAC, De MonredonJ, El AmraniM, RogerJC, ServeauxJ. Guillain-Barre"/>
 <result pre="infectious diseases. 2009;15:310.3201/eid1503.071482 31WielanekAC, De MonredonJ, El AmraniM, RogerJC, ServeauxJ." exact="Guillain-Barre syndrome" post="complicating a Chikungunya virus infection. Neurology. 2007;69(22):2105–7. 10.1212/01.wnl.0000277267.07220.8818040016 32Villamil-GomezW,"/>
 <result pre="diseases. 2009;15:310.3201/eid1503.071482 31WielanekAC, De MonredonJ, El AmraniM, RogerJC, ServeauxJ. Guillain-Barre" exact="syndrome" post="complicating a Chikungunya virus infection. Neurology. 2007;69(22):2105–7. 10.1212/01.wnl.0000277267.07220.8818040016 32Villamil-GomezW,"/>
 <result pre="De MonredonJ, El AmraniM, RogerJC, ServeauxJ. Guillain-Barre syndrome complicating a" exact="Chikungunya virus infection." post="Neurology. 2007;69(22):2105–7. 10.1212/01.wnl.0000277267.07220.8818040016 32Villamil-GomezW, SilveraLA, Paez-CastellanosJ, Rodriguez-MoralesA. Guillain-Barre syndrome"/>
 <result pre="MonredonJ, El AmraniM, RogerJC, ServeauxJ. Guillain-Barre syndrome complicating a Chikungunya" exact="virus infection." post="Neurology. 2007;69(22):2105–7. 10.1212/01.wnl.0000277267.07220.8818040016 32Villamil-GomezW, SilveraLA, Paez-CastellanosJ, Rodriguez-MoralesA. Guillain-Barre syndrome"/>
 <result pre="Chikungunya virus infection. Neurology. 2007;69(22):2105–7. 10.1212/01.wnl.0000277267.07220.8818040016 32Villamil-GomezW, SilveraLA, Paez-CastellanosJ, Rodriguez-MoralesA." exact="Guillain-Barre syndrome" post="after Chikungunya infection: A case in Colombia. Enfermedades infecciosas"/>
 <result pre="virus infection. Neurology. 2007;69(22):2105–7. 10.1212/01.wnl.0000277267.07220.8818040016 32Villamil-GomezW, SilveraLA, Paez-CastellanosJ, Rodriguez-MoralesA. Guillain-Barre" exact="syndrome" post="after Chikungunya infection: A case in Colombia. Enfermedades infecciosas"/>
 <result pre="virus infections: clinical manifestations, mortality and risk factors for severe" exact="disease" post="during the 2005-2006 outbreak on Reunion. Epidemiology and infectionApr."/>
 <result pre="Epidemiology and infectionApr. 2009;1(137):04. 34VictoraCG, Schuler-FacciniL, MatijasevichA, RibeiroE, PessoaA, BarrosF." exact="Microcephaly" post="in Brazil: how to interpret reported numbers?The Lancet. 2016;387(10019):621–4."/>
 <result pre="Brazil: how to interpret reported numbers?The Lancet. 2016;387(10019):621–4. 10.1016/S0140-6736(16)00273-7 35Pan" exact="American" post="Health Organization official website. The health-related fact sheets of"/>
 <result pre="Brazil. Sci Rep. 2017;7(1):27310.1038/s41598-017-00253-128325935 41HeD, IonidesEL, KingA. Plug-and-play inference for" exact="disease" post="dynamics: measles in large and small populations as a"/>
 <result pre="Rep. 2017;7(1):27310.1038/s41598-017-00253-128325935 41HeD, IonidesEL, KingA. Plug-and-play inference for disease dynamics:" exact="measles" post="in large and small populations as a case study."/>
 <result pre="CalvezE, GoarantC, Dupont-RouzeyrolM. Detection of Zika virus in urine. Emerging" exact="infectious diseases." post="2015;21(1):8410.3201/eid2101.14089425530324 43MussoD, RocheC, RobinE, NhanT, TeissierA, Cao-LormeauV. Potential sexual"/>
 <result pre="Dis. 2015;21(2):359–61. 10.3201/eid2102.14136325625872 44ZhaoS, StoneL, GaoD, HeD. Modelling the large-scale" exact="yellow fever" post="outbreak in Luanda, Angola, and the impact of vaccination."/>
 <result pre="One;;7:e4908510.1371/journal.pone.004908523139836 46ChikakiE, IshikawaHA. dengue transmission model in Thailand considering sequential" exact="infections" post="with all four serotypes. J Infect Dev Ctries. 2009;3:711–22."/>
 <result pre="four serotypes. J Infect Dev Ctries. 2009;3:711–22. 10.3855/jidc.61619858573 47BearcroftW. Zika" exact="virus infection" post="experimentally induced in a human volunteer. Transactions of the"/>
 <result pre="serotypes. J Infect Dev Ctries. 2009;3:711–22. 10.3855/jidc.61619858573 47BearcroftW. Zika virus" exact="infection" post="experimentally induced in a human volunteer. Transactions of the"/>
 <result pre="and Hygiene. 1956;50(5):442–8. 10.1016/0035-9203(56)90090-613380987 48BoormanJP, PorterfieldJ. A simple technique for" exact="infection" post="of mosquitoes with viruses transmission of Zika virus. Transactions"/>
 <result pre="and the extrinsic incubation period in 168 models of mosquito-borne" exact="disease" post="transmission and control. PLoS One. 2010;5:e1016510.1371/journal.pone.001016520405010 50YangHM, MacorisMD, GalvaniKC,"/>
 <result pre="Reproduction numbers and sub-threshold endemic equilibria for compartmental models of" exact="disease" post="transmission. Mathematical biosciences. 2002;180(1):29–48. 10.1016/s0025-5564(02)00108-612387915 54BrauerF, Castillo-ChavezC, MubayiA, TowersS."/>
 <result pre="Castillo-ChavezC, MubayiA, TowersS. Some models for epidemics of vector-transmitted diseases." exact="Infectious" post="Disease Modelling. 2016;1(1):79–87. 10.1016/j.idm.2016.08.00129928722 55SasmalSK, GhoshI, HuppertA, ChattopadhyayJ. Modeling"/>
 <result pre="MubayiA, TowersS. Some models for epidemics of vector-transmitted diseases. Infectious" exact="Disease" post="Modelling. 2016;1(1):79–87. 10.1016/j.idm.2016.08.00129928722 55SasmalSK, GhoshI, HuppertA, ChattopadhyayJ. Modeling the"/>
 <result pre="Mathematical epidemiology. Lecture Notes in Mathematics. 2008;1945:81–130. 10.1007/978-3-540-78911-6_3 57AndersonRM, RMM." exact="Infectious" post="diseases of humans: dynamics and control. Oxford: Oxford university"/>
 <result pre="et al.Time lags between exanthematous illness attributed to Zika virus," exact="Guillain-Barré syndrome," post="and microcephaly, Salvador, Brazil. Emerging infectious diseases. 2016;22(8):143810.3201/eid2208.16049627144515 62for"/>
 <result pre="to Zika virus, Guillain-Barré syndrome, and microcephaly, Salvador, Brazil. Emerging" exact="infectious diseases." post="2016;22(8):143810.3201/eid2208.16049627144515 62for Disease Control TC, official website PC. The"/>
 <result pre="syndrome, and microcephaly, Salvador, Brazil. Emerging infectious diseases. 2016;22(8):143810.3201/eid2208.16049627144515 62for" exact="Disease" post="Control TC, official website PC. The mosquito lifecycle fact"/>
 <result pre="https://www.cdc.gov/dengue/resources/factsheets/mosquitolifecyclefinal.pdf;. 63KraemerMU, FariaNR, ReinerRCJr, GoldingN, NikolayB, StasseS, et al.Spread of" exact="yellow fever" post="virus outbreak in Angola and the Democratic Republic of"/>
 <result pre="Republic of the Congo 2015–16: a modelling study. The Lancet" exact="infectious diseases." post="2017;17(3):330–338. 10.1016/S1473-3099(16)30513-828017559 64SchwarzG. Estimating the dimension of a model."/>
 <result pre="Softw. 2016;69:1–43. 66ZhaoS, LouY, ChiuAP, HeD. Modelling the skip-and-resurgence of" exact="Japanese encephalitis" post="epidemics in Hong Kong. Journal of theoretical biology. 2018;454:1–10."/>
 <result pre="2016;69:1–43. 66ZhaoS, LouY, ChiuAP, HeD. Modelling the skip-and-resurgence of Japanese" exact="encephalitis" post="epidemics in Hong Kong. Journal of theoretical biology. 2018;454:1–10."/>
 <result pre="28887877 70XiaoY, TangS, WuJ. Media impact switching surface during an" exact="infectious disease" post="outbreak. Scientific reports. 2015;5:783810.1038/srep0783825592757 71MusaSS, ZhaoS, ChanHS, JinZ, HeD."/>
 <result pre="70XiaoY, TangS, WuJ. Media impact switching surface during an infectious" exact="disease" post="outbreak. Scientific reports. 2015;5:783810.1038/srep0783825592757 71MusaSS, ZhaoS, ChanHS, JinZ, HeD."/>
 <result pre="engineering. 2019;16(5):3841–63. 10.3934/mbe.201919031499639 72BolkerBM, GrenfellB. Chaos and biological complexity in" exact="measles" post="dynamics. Proceedings of the Royal Society of London Series"/>
 <result pre="Biological Sciences. 1993;251(1330):75–81. 10.1098/rspb.1993.00118094567 73HeD, EarnD. The cohort effect in" exact="childhood" post="disease dynamics. Journal of The Royal Society Interface. 2016;13:2016015610.1098/rsif.2016.0156"/>
 <result pre="Sciences. 1993;251(1330):75–81. 10.1098/rspb.1993.00118094567 73HeD, EarnD. The cohort effect in childhood" exact="disease" post="dynamics. Journal of The Royal Society Interface. 2016;13:2016015610.1098/rsif.2016.0156 74HeD,"/>
 <result pre="Interface. 2016;13:2016015610.1098/rsif.2016.0156 74HeD, WangX, GaoD, WangJ. Modeling the 2016–2017 Yemen" exact="cholera" post="outbreak with the impact of limited medical resources. Journal"/>
 <result pre="Modeling the 2016–2017 Yemen cholera outbreak with the impact of" exact="limited" post="medical resources. Journal of theoretical biology. 2018;451:80–85. 10.1016/j.jtbi.2018.04.04129727633 75CousienA,"/>
 <result pre="Virus Transmission Within Households During an Outbreak in Martinique, 2015-2016." exact="American" post="journal of epidemiology. 2019;188(7):1389–1396. 10.1093/aje/kwz09130995296 76RubelF, BruggerK, HantelM, Chvala-MannsbergerS,"/>
 <result pre="2017;11(7):e000579710.1371/journal.pntd.000579728723920 78ZhaoS, BauchCT, HeD. Strategic decision making about travel during" exact="disease" post="outbreaks: a game theoretical approach. Journal of The Royal"/>
 <result pre="Modelling the influence of human behaviour on the spread of" exact="infectious" post="diseases: a review. Journal of the Royal Society Interface."/>
 <result pre="10.1126/science.aav661830733412 83GordonA, GreshL, OjedaS, KatzelnickLC, SanchezN, MercadoJC, et al.Prior dengue" exact="virus infection" post="and risk of Zika: A pediatric cohort in Nicaragua."/>
 <result pre="83GordonA, GreshL, OjedaS, KatzelnickLC, SanchezN, MercadoJC, et al.Prior dengue virus" exact="infection" post="and risk of Zika: A pediatric cohort in Nicaragua."/>
</results>
